Sofinnova Investments, Inc. Kura Oncology, Inc. Transaction History

Sofinnova Investments, Inc.

$1.06 Billion
Q3 2024

A detailed history of Sofinnova Investments, Inc. transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 296,884 shares of KURA stock, worth $2.67 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

296,884

Previous 825,243 64.02%

Holding current value

$2.67 Million

Previous $17 Million 65.86%

% of portfolio

0.55%

Previous 0.94%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$18.57 - $23.23 $9.81 Million - $12.3 Million	-528,359 Reduced 64.02%	296,884 $5.8 Million
Q2 2024 Aug 09, 2024	BUY	$17.53 - $22.98 $5.67 Million - $7.43 Million	323,303 Added 64.41%	825,243 $17 Million
Q1 2024 Aug 14, 2024	SELL	$13.42 - $23.53 $4.34 Million - $7.61 Million	-323,303 Reduced 39.18%	501,940 $10.7 Million
Q1 2024 May 15, 2024	SELL	$13.42 - $23.53 $15.6 Million - $27.4 Million	-1,165,381 Reduced 69.9%	501,940 $10.7 Million
Q4 2023 Aug 15, 2024	BUY	$7.58 - $14.38 $6.38 Million - $12.1 Million	842,078 Added 102.04%	1,667,321 $24 Million
Q4 2023 Feb 12, 2024	BUY	$7.58 - $14.38 $12.6 Million - $24 Million	1,667,321 New	1,667,321 $24 Million
Q1 2023 May 11, 2023	BUY	$10.71 - $14.6 $242,131 - $330,076	22,608 Added 3.81%	616,169 $7.54 Million
Q4 2022 Feb 13, 2023	BUY	$11.23 - $16.9 $6.67 Million - $10 Million	593,561 New	593,561 $7.37 Million
Q1 2022 May 16, 2022	SELL	$11.78 - $16.98 $4.35 Million - $6.27 Million	-369,173 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$12.22 - $19.57 $4.72 Million - $7.55 Million	-385,948 Reduced 51.11%	369,173 $5.17 Million
Q3 2021 Nov 15, 2021	BUY	$15.42 - $21.72 $4.79 Million - $6.75 Million	310,749 Added 69.93%	755,121 $14.1 Million
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $7.53 Million - $10.8 Million	361,208 Added 434.33%	444,372 $9.27 Million
Q1 2021 May 14, 2021	SELL	$24.75 - $39.14 $928,446 - $1.47 Million	-37,513 Reduced 31.09%	83,164 $2.35 Million
Q4 2020 Feb 16, 2021	SELL	$29.0 - $41.62 $3.03 Million - $4.35 Million	-104,582 Reduced 46.43%	120,677 $3.94 Million
Q3 2020 Nov 13, 2020	SELL	$16.3 - $30.64 $6.29 Million - $11.8 Million	-385,720 Reduced 63.13%	225,259 $6.9 Million
Q2 2020 Aug 13, 2020	BUY	$7.95 - $18.81 $4.86 Million - $11.5 Million	610,979 New	610,979 $9.96 Million
Q4 2018 Feb 14, 2019	SELL	$10.6 - $17.49 $2.62 Million - $4.33 Million	-247,385 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$16.65 - $21.85 $1.32 Million - $1.74 Million	79,485 Added 47.34%	247,385 $4.33 Million
Q2 2018 Nov 15, 2018	BUY	$14.8 - $18.8 $2.23 Million - $2.83 Million	150,605 Added 870.8%	167,900 $3.06 Million
Q2 2018 Aug 14, 2018	BUY	$14.8 - $18.8 $255,966 - $325,146	17,295 New	17,295 $315,000

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.

Account

Sofinnova Investments, Inc. Kura Oncology, Inc. Transaction History